Factors associated with treatment initiation after osteoporosis screening

American Journal of Epidemiology

Volumn 160, Issue 5, 2004, Pages 475-483

  Brennan, Renee M ^a   Wactawski Wende, Jean ^a,b   Crespo, Carlos J ^a   Dmochowski, Jacek ^c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

Bone density; Densitometry; Diagnosis; Drug therapy; Mass screening; Osteoporosis, postmenopause; Risk factors

Indexed keywords

DISEASE TREATMENT;

ADULT; AGED; ARTICLE; BONE DENSITY; DENSITOMETRY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; EDUCATION; FEMALE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MASS SCREENING; MEDICAL CARE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OSTEOPOROSIS; POSTMENOPAUSE; PREVALENCE; RISK ASSESSMENT;

AGED; BONE DENSITY; DENSITOMETRY, X-RAY; EDUCATIONAL STATUS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; INCOME; LOGISTIC MODELS; MASS SCREENING; NEW YORK; OSTEOPOROSIS, POSTMENOPAUSAL; PREVALENCE; QUESTIONNAIRES;

EID: 4444247628     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwh245     Document Type: Article

References (19)

1. Osteoporosis prevention, diagnosis, and therapy. NIH Consensus Statement 2000 March 27-29;17(1):1-36. (http://odp.od.nih.gov/consensus/cons/111/11_intro. htm).
2. America's bone health: the state of osteoporosis and low bone mass in our nation. Washington, DC: National Osteoporosis Foundation, 2004. (http://www.nof.org/advocacy/prevalence/index.htm).
3. Watts NB. Therapies to improve bone mineral density and reduce the risk of fracture: clinical trial results. J Reprod Med 2002;47(1 suppl):82-92.
4. Kulak CA, Bilezikian JP. Bone mass measurement in identification of women at risk for osteoporosis. Int J Fertil Womens Med 1999;44:269-78.
5. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785-95.
6. National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Hyattsville, MD: National Center for Health Statistics, 1994. (Vital and health statistics, series 1: programs and collection procedures, no. 32) (DHHS publication no. (PHS) 94-1308) (GPO no. 017-022-01260-0).
7. Siris E, Miller P, Barrett-Connor E, et al. Design of NORA, the National Osteoporosis Risk Assessment Program. Osteoporos Int 1998;8(suppl 1):S62-S69.
8. Rubin SM, Cummings SR. Results of bone densitometry affect women's decision about taking measures to prevent fractures. Ann Intern Med 1992;116:990-5.
9. Phillipov G, Mos E, Scinto S, et al. Initiation of hormone replacement therapy after diagnosis of osteoporosis by bone densitometry. Osteoporos Int 1997;7:162-4.
10. Torgerson DJ, Thomas RE, Campbell MK, et al. Randomized trial of osteoporosis screening. Use of hormone replacement therapy and quality-of-life results. Arch Intern Med 1997;157: 2121-5.
11. Cole RP, Palushock S, Haboubi A. Osteoporosis management: physicians' recommendations and women's compliance following osteoporosis testing. Womens Health 1999;29:101-15.
12. Marci CD, Viechnicki MB, Greenspan SL. Bone mineral densitometry substantially influences health-related behaviors of postmenopausal women. Calcif Tissue Int 2000;66:113-18.
13. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 1998;19:61-109.
14. Leib ES, Lewiecki EM, Binkley N, et al. Official positions of the International Society for Clinical Densitometry. J Clin Densitom 2004;7:1-6.
15. National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. Belle Meade, NJ: Excerpta Medica Inc, 1998.
16. Looker AC, Orwoll ES, Johnston CC, et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 1997;12:1761-8.
17. Population projections of the United States by age, sex, race, and Hispanic origin: 1995 to 2050. Washington, DC: US Census Bureau, 1996. (http://www.census.gov/prod/1/pop/p25-1130/).
18. Johnston CC Jr, Slemenda CW. Risk assessment: theoretical considerations. Am J Med 1993;95(5A):2S-5S.
19. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.